Development and Sustainable Release Evaluation of Enrofloxacin Solid Lipid Nanopartilces

Simple item page
dc.contributor.authorSenthilkumar, P.
dc.contributor.authorArivuchelvan, A.
dc.contributor.authorJagadeeswaran, A.
dc.contributor.authorSubramanian, N.
dc.contributor.authorSenthilkumar, C.
dc.contributor.authorMekala, P.
dc.contributor.authorTANUVAS
dc.date.accessioned2018-07-20T11:43:57Z
dc.date.available2018-07-20T11:43:57Z
dc.date.issued2014
dc.description.abstractThe study was conducted to formulate the enrofloxacin solid lipid nanoparticles (SLNs) with sustained release profile and improved pharmacological activity. The enrofloxacin SLNs were prepared using tripalmitin as lipid carrier, tween 80 and span 80 as surfactants and poly vinyl alcohol (PVA) as a stabilizer by a hot homogenization coupled with ultrasonication method. The formulation were characterized for particle size, polydispersity index, zeta potential (using dynamic light scattering), shape (using atomic force microscopy), drug encapsulation efficiency (using by dialysis and ultracentrifugation methods), and in vitro drug release (using by dialysis).en_US
dc.identifier.urihttp://krishikosh.egranth.ac.in/handle/1/5810061330
dc.keywordsVeterinary Science, Veterinary Pharmacology and Toxicologyen_US
dc.language.isoen_USen_US
dc.subjectVeterinary Scienceen_US
dc.subjectVeterinary Pharmacology and Toxicologyen_US
dc.titleDevelopment and Sustainable Release Evaluation of Enrofloxacin Solid Lipid Nanopartilcesen_US
dc.typeBook chapteren_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
TNV_BC_NPTT_2014_2.pdf
Size:
658.74 KB
Format:
Adobe Portable Document Format
Description:
TNV_BC_NPTT_2014_2
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Book Chapters (English)